| mrna processing | GO:0006397 | 63 | 0.759 | |
| gene silencing by mirna | GO:0035195 | 10 | 0.686 | |
| rna splicing | GO:0008380 | 54 | 0.660 | |
| mrna metabolic process | GO:0016071 | 84 | 0.635 | |
| mrna splicing via spliceosome | GO:0000398 | 43 | 0.557 | |
| histone modification | GO:0016570 | 159 | 0.416 | |
| dna metabolic process | GO:0006259 | 303 | 0.395 | |
| rna processing | GO:0006396 | 105 | 0.394 | |
| regulation of rna splicing | GO:0043484 | 37 | 0.393 | |
| histone methylation | GO:0016571 | 71 | 0.390 | |
| pre mirna processing | GO:0031054 | 3 | 0.384 | |
| rna splicing via transesterification reactions | GO:0000375 | 43 | 0.360 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.322 | |
| regulation of mrna metabolic process | GO:1903311 | 43 | 0.293 | |
| primary mirna processing | GO:0031053 | 1 | 0.275 | |
| chromatin modification | GO:0016568 | 187 | 0.254 | |
| cytoplasmic pattern recognition receptor signaling pathway in response to virus | GO:0039528 | 4 | 0.233 | |
| regulation of mrna splicing via spliceosome | GO:0048024 | 32 | 0.232 | |
| positive regulation of dna templated transcription elongation | GO:0032786 | 2 | 0.228 | |
| production of small rna involved in gene silencing by rna | GO:0070918 | 6 | 0.226 | |
| protein methylation | GO:0006479 | 81 | 0.200 | |
| rna splicing via transesterification reactions with bulged adenosine as nucleophile | GO:0000377 | 43 | 0.198 | |
| nuclear division | GO:0000280 | 158 | 0.187 | |
| stem cell development | GO:0048864 | 219 | 0.185 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.174 | |
| regulation of mrna processing | GO:0050684 | 41 | 0.171 | |
| stem cell differentiation | GO:0048863 | 268 | 0.150 | |
| stem cell maintenance | GO:0019827 | 130 | 0.149 | |
| organelle fission | GO:0048285 | 170 | 0.136 | |
| chromatin organization | GO:0006325 | 206 | 0.133 | |
| multicellular organism growth | GO:0035264 | 161 | 0.128 | |
| dna repair | GO:0006281 | 107 | 0.127 | |
| symbiosis encompassing mutualism through parasitism | GO:0044403 | 83 | 0.126 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.125 | |
| positive regulation of transcription elongation from rna polymerase ii promoter | GO:0032968 | 2 | 0.118 | |
| microtubule severing | GO:0051013 | 5 | 0.118 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.111 | |
| positive regulation of gene silencing by mirna | GO:2000637 | 1 | 0.109 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.108 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.104 | |
| alternative mrna splicing via spliceosome | GO:0000380 | 12 | 0.103 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.095 | |
| regulation of histone methylation | GO:0031060 | 30 | 0.094 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.090 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.089 | |
| heart morphogenesis | GO:0003007 | 178 | 0.087 | |
| establishment of rna localization | GO:0051236 | 18 | 0.085 | |
| germ cell development | GO:0007281 | 185 | 0.085 | |
| regulation of synaptic growth at neuromuscular junction | GO:0008582 | 4 | 0.084 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.081 | |
| positive regulation of myelination | GO:0031643 | 5 | 0.078 | |
| microtubule based process | GO:0007017 | 236 | 0.076 | |
| regulation of schwann cell proliferation | GO:0010624 | 2 | 0.074 | |
| regionalization | GO:0003002 | 337 | 0.073 | |
| olfactory learning | GO:0008355 | 2 | 0.072 | |
| regulation of alternative mrna splicing via spliceosome | GO:0000381 | 8 | 0.071 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.071 | |
| regulation of chromosome organization | GO:0033044 | 83 | 0.069 | |
| meiotic cell cycle | GO:0051321 | 122 | 0.069 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.068 | |
| negative regulation of mrna processing | GO:0050686 | 12 | 0.064 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.064 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.063 | |
| dna methylation involved in gamete generation | GO:0043046 | 15 | 0.063 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.061 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.061 | |
| protein alkylation | GO:0008213 | 81 | 0.061 | |
| myoblast differentiation involved in skeletal muscle regeneration | GO:0014835 | 3 | 0.060 | |
| viral process | GO:0016032 | 41 | 0.057 | |
| macromolecule methylation | GO:0043414 | 120 | 0.057 | |
| nucleic acid transport | GO:0050657 | 18 | 0.056 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.056 | |
| rna interference | GO:0016246 | 2 | 0.054 | |
| negative regulation of gene expression epigenetic | GO:0045814 | 15 | 0.054 | |
| skeletal system development | GO:0001501 | 356 | 0.054 | |
| cellularization | GO:0007349 | 1 | 0.054 | |
| male gamete generation | GO:0048232 | 285 | 0.054 | |
| apoptotic nuclear changes | GO:0030262 | 9 | 0.054 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.053 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.053 | |
| rig i signaling pathway | GO:0039529 | 4 | 0.051 | |
| respiratory tube development | GO:0030323 | 167 | 0.051 | |
| spermatogenesis | GO:0007283 | 284 | 0.050 | |
| histone lysine methylation | GO:0034968 | 50 | 0.050 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.048 | |
| dsrna fragmentation | GO:0031050 | 6 | 0.048 | |
| regulation of transcription during meiosis | GO:0051037 | 1 | 0.048 | |
| posttranscriptional gene silencing | GO:0016441 | 10 | 0.047 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.046 | |
| histone deubiquitination | GO:0016578 | 2 | 0.046 | |
| immune effector process | GO:0002252 | 321 | 0.045 | |
| negative regulation of mesenchymal cell proliferation | GO:0072201 | 3 | 0.045 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.044 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.044 | |
| blastocyst development | GO:0001824 | 80 | 0.044 | |
| negative regulation of synapse assembly | GO:0051964 | 3 | 0.044 | |
| viral life cycle | GO:0019058 | 36 | 0.043 | |
| germ line stem cell division | GO:0042078 | 2 | 0.042 | |
| positive regulation of neuron projection development | GO:0010976 | 79 | 0.042 | |
| meiotic cell cycle process | GO:1903046 | 77 | 0.042 | |
| rna transport | GO:0050658 | 18 | 0.041 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.041 | |
| protein acylation | GO:0043543 | 64 | 0.040 | |
| stem cell fate specification | GO:0048866 | 3 | 0.040 | |
| methylation | GO:0032259 | 134 | 0.040 | |
| wound healing | GO:0042060 | 157 | 0.039 | |
| transcription coupled nucleotide excision repair | GO:0006283 | 2 | 0.039 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.039 | |
| nucleobase containing compound transport | GO:0015931 | 27 | 0.038 | |
| regulation of cell cycle checkpoint | GO:1901976 | 9 | 0.037 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.037 | |
| regulation of protein complex disassembly | GO:0043244 | 28 | 0.037 | |
| schwann cell proliferation | GO:0014010 | 2 | 0.037 | |
| chromosome segregation | GO:0007059 | 48 | 0.037 | |
| regulation of chromatin silencing | GO:0031935 | 2 | 0.036 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.036 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.036 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.036 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.035 | |
| positive regulation of mrna processing | GO:0050685 | 16 | 0.035 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.035 | |
| chromatin assembly | GO:0031497 | 13 | 0.035 | |
| negative regulation of schwann cell proliferation | GO:0010626 | 1 | 0.034 | |
| regulation of chromatin modification | GO:1903308 | 57 | 0.034 | |
| central nervous system neuron differentiation | GO:0021953 | 162 | 0.034 | |
| muscle tissue development | GO:0060537 | 308 | 0.034 | |
| negative regulation of cell cycle | GO:0045786 | 123 | 0.033 | |
| posttranscriptional gene silencing by rna | GO:0035194 | 10 | 0.033 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.033 | |
| amine metabolic process | GO:0009308 | 45 | 0.032 | |
| spermatid development | GO:0007286 | 108 | 0.032 | |
| peptidyl tyrosine phosphorylation | GO:0018108 | 143 | 0.032 | |
| viral genome replication | GO:0019079 | 17 | 0.031 | |
| cell division | GO:0051301 | 120 | 0.031 | |
| meiotic nuclear division | GO:0007126 | 115 | 0.030 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.030 | |
| defense response to other organism | GO:0098542 | 197 | 0.029 | |
| interspecies interaction between organisms | GO:0044419 | 83 | 0.029 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.029 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.029 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.029 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.028 | |
| axonogenesis | GO:0007409 | 274 | 0.027 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.027 | |
| cellular component disassembly involved in execution phase of apoptosis | GO:0006921 | 9 | 0.027 | |
| execution phase of apoptosis | GO:0097194 | 19 | 0.027 | |
| regulation of nuclear division | GO:0051783 | 56 | 0.027 | |
| negative regulation of mrna metabolic process | GO:1903312 | 13 | 0.027 | |
| angiogenesis | GO:0001525 | 201 | 0.027 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.027 | |
| regulation of system process | GO:0044057 | 200 | 0.027 | |
| somatic stem cell maintenance | GO:0035019 | 47 | 0.027 | |
| transcription elongation from rna polymerase ii promoter | GO:0006368 | 9 | 0.027 | |
| segmentation | GO:0035282 | 93 | 0.027 | |
| neuron projection guidance | GO:0097485 | 141 | 0.027 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.026 | |
| rhythmic process | GO:0048511 | 174 | 0.026 | |
| lipid localization | GO:0010876 | 126 | 0.026 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.026 | |
| protein oligomerization | GO:0051259 | 67 | 0.026 | |
| ribonucleoprotein complex subunit organization | GO:0071826 | 28 | 0.026 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.026 | |
| circadian rhythm | GO:0007623 | 114 | 0.025 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.025 | |
| regulation of dna templated transcription elongation | GO:0032784 | 10 | 0.025 | |
| mitotic nuclear division | GO:0007067 | 48 | 0.025 | |
| regulation of response to dna damage stimulus | GO:2001020 | 34 | 0.025 | |
| genetic imprinting | GO:0071514 | 27 | 0.025 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.025 | |
| lung development | GO:0030324 | 164 | 0.024 | |
| response to radiation | GO:0009314 | 165 | 0.024 | |
| regulation of multi organism process | GO:0043900 | 111 | 0.024 | |
| smad protein signal transduction | GO:0060395 | 21 | 0.024 | |
| synapse assembly | GO:0007416 | 56 | 0.024 | |
| digestive system development | GO:0055123 | 200 | 0.024 | |
| negative regulation of organelle organization | GO:0010639 | 90 | 0.024 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.024 | |
| response to insulin | GO:0032868 | 100 | 0.024 | |
| positive regulation of posttranscriptional gene silencing | GO:0060148 | 1 | 0.023 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.023 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.023 | |
| dsrna transport | GO:0033227 | 1 | 0.023 | |
| immune response regulating signaling pathway | GO:0002764 | 125 | 0.023 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.023 | |
| sensory perception | GO:0007600 | 245 | 0.023 | |
| nuclear transport | GO:0051169 | 139 | 0.023 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.023 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.022 | |
| regulation of purine nucleotide catabolic process | GO:0033121 | 122 | 0.022 | |
| respiratory system development | GO:0060541 | 190 | 0.022 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.022 | |
| positive regulation of growth | GO:0045927 | 104 | 0.022 | |
| regulation of cell size | GO:0008361 | 72 | 0.022 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.022 | |
| regulation of translation | GO:0006417 | 71 | 0.022 | |
| dna catabolic process endonucleolytic | GO:0000737 | 15 | 0.022 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.022 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.022 | |
| ear development | GO:0043583 | 200 | 0.022 | |
| cognition | GO:0050890 | 149 | 0.022 | |
| synapse organization | GO:0050808 | 125 | 0.021 | |
| regulation of transcription from rna polymerase iii promoter | GO:0006359 | 2 | 0.021 | |
| adult behavior | GO:0030534 | 135 | 0.021 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.021 | |
| chromatin silencing at rdna | GO:0000183 | 3 | 0.021 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.021 | |
| regulation of histone modification | GO:0031056 | 56 | 0.021 | |
| dna conformation change | GO:0071103 | 37 | 0.020 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.020 | |
| positive regulation of cell projection organization | GO:0031346 | 95 | 0.020 | |
| embryonic skeletal system development | GO:0048706 | 120 | 0.020 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.020 | |
| epithelial cell development | GO:0002064 | 159 | 0.020 | |
| locomotory behavior | GO:0007626 | 195 | 0.020 | |
| rna catabolic process | GO:0006401 | 29 | 0.020 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.020 | |
| double strand break repair | GO:0006302 | 48 | 0.020 | |
| cellular response to dsrna | GO:0071359 | 12 | 0.020 | |
| b cell activation | GO:0042113 | 161 | 0.019 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.019 | |
| action potential | GO:0001508 | 78 | 0.019 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.019 | |
| gonad morphogenesis | GO:0035262 | 1 | 0.019 | |
| rna phosphodiester bond hydrolysis endonucleolytic | GO:0090502 | 10 | 0.019 | |
| neural tube development | GO:0021915 | 160 | 0.019 | |
| olfactory bulb development | GO:0021772 | 30 | 0.019 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.019 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.019 | |
| negative regulation of multi organism process | GO:0043901 | 68 | 0.019 | |
| blastocyst growth | GO:0001832 | 23 | 0.019 | |
| cartilage development | GO:0051216 | 140 | 0.019 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.019 | |
| response to starvation | GO:0042594 | 65 | 0.019 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.019 | |
| transcription from rna polymerase iii promoter | GO:0006383 | 3 | 0.019 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.018 | |
| regulation of interferon beta production | GO:0032648 | 13 | 0.018 | |
| digestive tract development | GO:0048565 | 190 | 0.018 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.018 | |
| negative regulation of mrna splicing via spliceosome | GO:0048025 | 12 | 0.018 | |
| positive regulation of immune effector process | GO:0002699 | 107 | 0.018 | |
| peptidyl tyrosine modification | GO:0018212 | 145 | 0.018 | |
| dna templated transcription elongation | GO:0006354 | 13 | 0.018 | |
| cellular response to biotic stimulus | GO:0071216 | 92 | 0.018 | |
| spindle organization | GO:0007051 | 28 | 0.018 | |
| olfactory lobe development | GO:0021988 | 32 | 0.018 | |
| learning | GO:0007612 | 98 | 0.018 | |
| dna methylation | GO:0006306 | 43 | 0.018 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.018 | |
| regulation of circadian rhythm | GO:0042752 | 58 | 0.018 | |
| positive regulation of type i interferon production | GO:0032481 | 14 | 0.018 | |
| response to nutrient levels | GO:0031667 | 109 | 0.018 | |
| compound eye development | GO:0048749 | 1 | 0.017 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.017 | |
| positive regulation of defense response | GO:0031349 | 124 | 0.017 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.017 | |
| spermatid differentiation | GO:0048515 | 115 | 0.017 | |
| dendrite development | GO:0016358 | 115 | 0.017 | |
| response to peptide | GO:1901652 | 136 | 0.017 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.017 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.017 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.017 | |
| response to monosaccharide | GO:0034284 | 67 | 0.017 | |
| regulation of chromatin organization | GO:1902275 | 57 | 0.017 | |
| neural tube formation | GO:0001841 | 108 | 0.017 | |
| regulation of synapse assembly | GO:0051963 | 29 | 0.017 | |
| placenta development | GO:0001890 | 140 | 0.017 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.017 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.017 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.017 | |
| embryonic skeletal system morphogenesis | GO:0048704 | 91 | 0.017 | |
| organelle assembly | GO:0070925 | 177 | 0.017 | |
| response to light stimulus | GO:0009416 | 135 | 0.017 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.017 | |
| regulation of mirna metabolic process | GO:2000628 | 4 | 0.016 | |
| pole plasm assembly | GO:0007315 | 2 | 0.016 | |
| innate immune response | GO:0045087 | 157 | 0.016 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.016 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.016 | |
| regulation of symbiosis encompassing mutualism through parasitism | GO:0043903 | 52 | 0.016 | |
| regulation of myeloid leukocyte differentiation | GO:0002761 | 58 | 0.016 | |
| glucose homeostasis | GO:0042593 | 128 | 0.016 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.016 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.016 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.016 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.016 | |
| biomineral tissue development | GO:0031214 | 64 | 0.016 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.016 | |
| cellular component assembly involved in morphogenesis | GO:0010927 | 139 | 0.016 | |
| positive regulation of synaptic growth at neuromuscular junction | GO:0045887 | 1 | 0.016 | |
| associative learning | GO:0008306 | 61 | 0.016 | |
| regulation of odontogenesis | GO:0042481 | 18 | 0.016 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.016 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.015 | |
| protein ubiquitination | GO:0016567 | 171 | 0.015 | |
| gene silencing | GO:0016458 | 38 | 0.015 | |
| single fertilization | GO:0007338 | 82 | 0.015 | |
| gland development | GO:0048732 | 330 | 0.015 | |
| hair cycle | GO:0042633 | 90 | 0.015 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.015 | |
| defense response to gram negative bacterium | GO:0050829 | 28 | 0.015 | |
| meiosis i | GO:0007127 | 60 | 0.015 | |
| positive regulation of cell morphogenesis involved in differentiation | GO:0010770 | 72 | 0.015 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.015 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.015 | |
| nucleosome positioning | GO:0016584 | 4 | 0.015 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.015 | |
| ventricular system development | GO:0021591 | 27 | 0.015 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.015 | |
| nuclear transcribed mrna catabolic process nonsense mediated decay | GO:0000184 | 1 | 0.015 | |
| skin development | GO:0043588 | 220 | 0.015 | |
| cellular response to organic cyclic compound | GO:0071407 | 87 | 0.015 | |
| guanosine containing compound metabolic process | GO:1901068 | 144 | 0.015 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.015 | |
| multi organism behavior | GO:0051705 | 62 | 0.015 | |
| activation of immune response | GO:0002253 | 138 | 0.015 | |
| embryonic limb morphogenesis | GO:0030326 | 126 | 0.014 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.014 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.014 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.014 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.014 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.014 | |
| positive regulation of leukocyte differentiation | GO:1902107 | 86 | 0.014 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.014 | |
| regulation of cell motility | GO:2000145 | 236 | 0.014 | |
| developmental cell growth | GO:0048588 | 84 | 0.014 | |
| gene silencing by rna | GO:0031047 | 19 | 0.014 | |
| gonad development | GO:0008406 | 141 | 0.014 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.014 | |
| mirna metabolic process | GO:0010586 | 10 | 0.014 | |
| oogenesis | GO:0048477 | 56 | 0.014 | |
| regulation of dna damage checkpoint | GO:2000001 | 3 | 0.014 | |
| male meiosis | GO:0007140 | 37 | 0.014 | |
| dna alkylation | GO:0006305 | 43 | 0.014 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.013 | |
| protein refolding | GO:0042026 | 1 | 0.013 | |
| chromatin silencing | GO:0006342 | 15 | 0.013 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.013 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.013 | |
| positive regulation of nucleotide catabolic process | GO:0030813 | 88 | 0.013 | |
| peptidyl lysine methylation | GO:0018022 | 29 | 0.013 | |
| apoptotic dna fragmentation | GO:0006309 | 7 | 0.013 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.013 | |
| protein autophosphorylation | GO:0046777 | 61 | 0.013 | |
| lymphocyte mediated immunity | GO:0002449 | 139 | 0.013 | |
| learning or memory | GO:0007611 | 148 | 0.013 | |
| synaptic transmission | GO:0007268 | 329 | 0.013 | |
| negative regulation of protein complex disassembly | GO:0043242 | 22 | 0.013 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.013 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 151 | 0.013 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.013 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.013 | |
| male sex differentiation | GO:0046661 | 109 | 0.013 | |
| regulation of viral genome replication | GO:0045069 | 13 | 0.013 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.013 | |
| pattern recognition receptor signaling pathway | GO:0002221 | 47 | 0.013 | |
| axon ensheathment | GO:0008366 | 76 | 0.013 | |
| intracellular receptor signaling pathway | GO:0030522 | 74 | 0.013 | |
| negative regulation of growth | GO:0045926 | 99 | 0.013 | |
| cell differentiation in spinal cord | GO:0021515 | 53 | 0.013 | |
| male anatomical structure morphogenesis | GO:0090598 | 4 | 0.013 | |
| protein localization to nucleus | GO:0034504 | 121 | 0.013 | |
| regulation of protein transport | GO:0051223 | 163 | 0.013 | |
| histone h3 k14 acetylation | GO:0044154 | 3 | 0.013 | |
| negative regulation of cellular catabolic process | GO:0031330 | 47 | 0.013 | |
| isotype switching | GO:0045190 | 36 | 0.013 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.013 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.013 | |
| forebrain development | GO:0030900 | 302 | 0.013 | |
| female sex differentiation | GO:0046660 | 84 | 0.012 | |
| myosin filament assembly | GO:0031034 | 2 | 0.012 | |
| regulation of insulin receptor signaling pathway | GO:0046626 | 21 | 0.012 | |
| schwann cell development | GO:0014044 | 22 | 0.012 | |
| cell activation involved in immune response | GO:0002263 | 126 | 0.012 | |
| limb development | GO:0060173 | 166 | 0.012 | |
| histone h3 acetylation | GO:0043966 | 14 | 0.012 | |
| nucleocytoplasmic transport | GO:0006913 | 139 | 0.012 | |
| defense response to virus | GO:0051607 | 68 | 0.012 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.012 | |
| neuronal action potential | GO:0019228 | 54 | 0.012 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.012 | |
| negative regulation of cytokine production | GO:0001818 | 84 | 0.012 | |
| cell growth | GO:0016049 | 130 | 0.012 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.012 | |
| peptide hormone secretion | GO:0030072 | 109 | 0.012 | |
| ubiquitin dependent protein catabolic process | GO:0006511 | 129 | 0.012 | |
| cellular response to insulin stimulus | GO:0032869 | 78 | 0.012 | |
| cellular carbohydrate metabolic process | GO:0044262 | 119 | 0.012 | |
| negative regulation of rna splicing | GO:0033119 | 12 | 0.012 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.012 | |
| regulation of myelination | GO:0031641 | 20 | 0.012 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.012 | |
| peptidyl lysine modification | GO:0018205 | 77 | 0.012 | |
| negative regulation of glial cell proliferation | GO:0060253 | 4 | 0.012 | |
| endomembrane system organization | GO:0010256 | 147 | 0.012 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.012 | |
| regulation of rig i signaling pathway | GO:0039535 | 2 | 0.012 | |
| positive regulation of rna splicing | GO:0033120 | 12 | 0.012 | |
| i kappab kinase nf kappab signaling | GO:0007249 | 85 | 0.012 | |
| proteasomal protein catabolic process | GO:0010498 | 98 | 0.012 | |
| regulation of secretion | GO:0051046 | 274 | 0.012 | |
| molting cycle | GO:0042303 | 90 | 0.012 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.012 | |
| peptide secretion | GO:0002790 | 114 | 0.012 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.012 | |
| limb morphogenesis | GO:0035108 | 149 | 0.012 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.012 | |
| positive regulation of wnt signaling pathway | GO:0030177 | 45 | 0.012 | |
| neural crest cell differentiation | GO:0014033 | 54 | 0.012 | |
| cytokine production | GO:0001816 | 319 | 0.012 | |
| protein localization to plasma membrane | GO:0072659 | 57 | 0.012 | |
| mesenchymal cell development | GO:0014031 | 93 | 0.012 | |
| positive regulation of myeloid cell differentiation | GO:0045639 | 43 | 0.012 | |
| skeletal muscle cell differentiation | GO:0035914 | 66 | 0.012 | |
| cellular response to oxidative stress | GO:0034599 | 76 | 0.012 | |
| cell adhesion | GO:0007155 | 329 | 0.012 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.012 | |
| regulation of cell division | GO:0051302 | 76 | 0.012 | |
| connective tissue development | GO:0061448 | 179 | 0.011 | |
| regulation of protein catabolic process | GO:0042176 | 108 | 0.011 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.011 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.011 | |
| sequestering of calcium ion | GO:0051208 | 18 | 0.011 | |
| telencephalon development | GO:0021537 | 186 | 0.011 | |
| peptidyl serine modification | GO:0018209 | 83 | 0.011 | |
| spinal cord development | GO:0021510 | 81 | 0.011 | |
| nerve development | GO:0021675 | 67 | 0.011 | |
| positive regulation of protein catabolic process | GO:0045732 | 60 | 0.011 | |
| positive regulation of mirna metabolic process | GO:2000630 | 1 | 0.011 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.011 | |
| asymmetric stem cell division | GO:0098722 | 3 | 0.011 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.011 | |
| neural precursor cell proliferation | GO:0061351 | 121 | 0.011 | |
| visual behavior | GO:0007632 | 45 | 0.011 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.011 | |
| negative regulation of immune effector process | GO:0002698 | 55 | 0.011 | |
| regulation of tooth mineralization | GO:0070170 | 2 | 0.011 | |
| membrane organization | GO:0061024 | 245 | 0.011 | |
| cytoplasmic pattern recognition receptor signaling pathway | GO:0002753 | 10 | 0.011 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.011 | |
| gtp metabolic process | GO:0046039 | 144 | 0.011 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.011 | |
| rna localization | GO:0006403 | 23 | 0.011 | |
| axon guidance | GO:0007411 | 141 | 0.011 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.011 | |
| camera type eye development | GO:0043010 | 266 | 0.011 | |
| maintenance of location | GO:0051235 | 89 | 0.011 | |
| intracellular protein transport | GO:0006886 | 204 | 0.011 | |
| histone acetylation | GO:0016573 | 41 | 0.011 | |
| cerebral cortex development | GO:0021987 | 86 | 0.011 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 133 | 0.011 | |
| regulation of cell projection assembly | GO:0060491 | 38 | 0.011 | |
| septum primum development | GO:0003284 | 4 | 0.011 | |
| negative regulation of mesenchymal cell proliferation involved in lung development | GO:2000791 | 2 | 0.011 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.011 | |
| ncrna processing | GO:0034470 | 26 | 0.010 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.010 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.010 | |
| asymmetric neuroblast division | GO:0055059 | 1 | 0.010 | |
| platelet derived growth factor receptor alpha signaling pathway | GO:0035790 | 3 | 0.010 | |
| oligodendrocyte differentiation | GO:0048709 | 53 | 0.010 | |
| negative regulation of chromosome organization | GO:2001251 | 30 | 0.010 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.010 | |
| male genitalia morphogenesis | GO:0048808 | 4 | 0.010 | |
| reactive nitrogen species metabolic process | GO:2001057 | 0 | 0.010 | |
| oocyte construction | GO:0007308 | 2 | 0.010 | |
| cell cycle checkpoint | GO:0000075 | 47 | 0.010 | |
| dna dependent dna replication maintenance of fidelity | GO:0045005 | 3 | 0.010 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.010 | |
| mapk cascade | GO:0000165 | 281 | 0.010 | |
| regulation of muscle tissue development | GO:1901861 | 97 | 0.010 | |
| receptor mediated endocytosis | GO:0006898 | 51 | 0.010 | |
| protein dna complex subunit organization | GO:0071824 | 28 | 0.010 | |
| epithelial tube formation | GO:0072175 | 130 | 0.010 | |
| somatic diversification of immune receptors via germline recombination within a single locus | GO:0002562 | 51 | 0.010 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.010 | |
| response to acid chemical | GO:0001101 | 111 | 0.010 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.010 | |
| ribonucleoside monophosphate catabolic process | GO:0009158 | 57 | 0.010 | |
